2型糖尿病、肥胖与健康体重青少年的骨量与骨密度
横断面研究比较10–23岁2型糖尿病(n=180)、肥胖(BMI>95th,n=226)与健康体重(BMI<85th,n=238)青少年的骨健康。儿童期2型糖尿病组aBMD与LBMI z评分高于肥胖组,而青少年和年轻成人中则低于肥胖组(年龄交互P<0.05)。2型糖尿病与肥胖组在相同LBMI z评分下aBMD较健康体重低约0.5 SD(P<0.05),内脏脂肪越多aBMD越低(β=-0.121,P=0.047)。
要点
- 儿童期2型糖尿病组aBMD与LBMI z评分高于肥胖组,青少年和年轻成人中则低于肥胖组(年龄交互P<0.05)。
- 2型糖尿病与肥胖组在相同LBMI z评分下aBMD较健康体重低约0.5 SD(P<0.05)。
- 内脏脂肪越多aBMD越低(β=-0.121,P=0.047)。
核心结论
- 结果提示2型糖尿病可能在骨量峰值年龄前后对骨密度产生不利影响。
- 鉴于成人2型糖尿病骨折风险增加,迫切需要纵向研究理解糖尿病对发育中骨骼的影响。
研究设计与样本
- 横断面研究,纳入10–23岁青少年(56%非裔美国人,67%女性),分为2型糖尿病组(n=180)、肥胖组(BMI>95th,n=226)和健康体重组(BMI<85th,n=238)。
- 通过DXA评估全身(不含头)aBMD、瘦体重和腹部内脏脂肪,并使用已发表的参考数据计算瘦体重BMI(LBMI)和aBMD的SD评分(z评分)。
主要发现
- 健康体重、肥胖和2型糖尿病组之间aBMD与LBMI z评分存在年龄依赖性差异(年龄交互P<0.05)。
- 儿童中,2型糖尿病组aBMD与LBMI z评分高于肥胖组;青少年和年轻成人中,2型糖尿病组aBMD与LBMI z评分低于肥胖组(年龄交互P<0.05)。
- 2型糖尿病组和肥胖组在相同LBMI z评分下aBMD较健康体重对照组低约0.5 SD(P<0.05)。
- 内脏脂肪越多aBMD越低(β=-0.121,P=0.047)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Youth-onset type 2 diabetes is an aggressive condition with increasing incidence. Adults with type 2 diabetes have increased fracture risk despite normal areal bone mineral density (aBMD), but the influence of diabetes on the growing skeleton is unknown. We compared bone health in youth with type 2 diabetes to control patients with obesity or healthy weight. RESEARCH DESIGN AND METHODS: Cross-sectional study of youth (56% African American, 67% female) ages 10-23 years with type 2 diabetes (n = 180), obesity (BMI >95th; n = 226), or healthy weight (BMI <85th; n = 238). Whole-body (less head) aBMD and lean mass as well as abdominal visceral fat were assessed via DXA. Lean BMI (LBMI) and aBMD SD scores (z scores) were computed using published reference data. RESULTS: We observed age-dependent differences in aBMD and LBMI z scores between the healthy weight, obese, and type 2 diabetes groups. In children, aBMD and LBMI z scores were greater in the type 2 diabetes group versus the obese group, but in adolescents and young adults, aBMD and LBMI z scores were lower in the type 2 diabetes group versus the obese group (age interactions P < 0.05). In the type 2 diabetes group and the obese group, aBMD was about 0.5 SDs lower for a given LBMI z score compared with healthy weight control patients (P < 0.05). Further, aBMD was lower in those with greater visceral fat (β = -0.121, P = 0.047). CONCLUSIONS: These results suggest that type 2 diabetes may be detrimental to bone density around the age of peak bone mass. Given the increased fracture risk in adults with type 2 diabetes, there is a pressing need for longitudinal studies aimed at understanding the influence of diabetes on the growing skeleton.
引用
- Kindler JM, Kelly A, Khoury PR, et al. Bone Mass and Density in Youth With Type 2 Diabetes, Obesity, and Healthy Weight. Diabetes Care. 2020. PMID: 32778556. doi:10.2337/dc19-2164
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。